Skip to content
Biophytis
LIVE HEALTHIER LONGER
Corporate
Executive Committee
Scientific Advisory Board
Boards of Directors
Code of Ethics
Our Science
Ruvembri
Posters & Publications
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Macuneos (BIO201)
Posters & Publications
Pipeline
Pipeline
Key milestones in the development of Ruvembri
COVID-19: COVA clinical program
Sarcopenia: SARA clinical program
Duchenne Muscular Dystrophy: MYODA clinical program
Age-related Macular Degeneration: MACA clinical program
Investors
Live Stock Price
Corporate Presentation
General Meetings
2024
2023
2022
2021
2020
AMF Regulated Information
SEC Filings
Financial Calendar
News
Press Releases
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Biophytis in Media
Recruitment
Contact
Contact
Contact Information
Legal information
LinkedIn
Twitter
FR
EN
Corporate
Executive Committee
Scientific Advisory Board
Boards of Directors
Code of Ethics
Our Science
Ruvembri
Posters & Publications
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Macuneos (BIO201)
Posters & Publications
Pipeline
Pipeline
Key milestones in the development of Ruvembri
COVID-19: COVA clinical program
Sarcopenia: SARA clinical program
Duchenne Muscular Dystrophy: MYODA clinical program
Age-related Macular Degeneration: MACA clinical program
Investors
Live Stock Price
Corporate Presentation
General Meetings
2024
2023
2022
2021
2020
AMF Regulated Information
SEC Filings
Financial Calendar
News
Press Releases
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Biophytis in Media
Recruitment
Contact
Contact
Contact Information
Legal information
LinkedIn
Twitter
FR
EN
Daily Archives:
28 May 2021
MAY 28, 2021
Média
By
Marie Paule Julienne
28 May 2021
Interview of Stanislas Veillet on Boursier.com
Go to Top